RAA

INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps

Retrieved on: 
Monday, March 11, 2024

INHALE-3 is a Phase 4 U.S. clinical trial evaluating inhaled insulin (plus basal) vs. standard of care.

Key Points: 
  • INHALE-3 is a Phase 4 U.S. clinical trial evaluating inhaled insulin (plus basal) vs. standard of care.
  • “In this large, randomized trial utilizing more appropriate dose conversion, we are excited to see meal challenge results support the safety and efficacy of inhaled insulin from the start.”
    INHALE-3 is a 17-week randomized controlled trial with a 13-week extension.
  • Subjects utilizing inhaled insulin received a higher initial conversion dose than in the current label.
  • For the meal challenge, the inhaled insulin group took an inhaled insulin dose immediately prior to a standardized meal (a 240 calorie nutritional shake) whereas those using usual care used RAA 5-15 minutes prior to the meal.

MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8

Retrieved on: 
Tuesday, March 5, 2024

INHALE-3 is a Phase 4 U.S. clinical trial evaluating inhaled insulin (plus basal) vs. standard of care.

Key Points: 
  • INHALE-3 is a Phase 4 U.S. clinical trial evaluating inhaled insulin (plus basal) vs. standard of care.
  • “With ABC and this trial, we used a higher initial conversion dose for inhaled insulin than in our current label.
  • In the ABC study, this conversion dose produced significantly lowered post-prandial glucose levels that peaked 30 minutes sooner than standard of care.
  • More information on the study is available at: ClinicalTrials.gov(NCT05904743) .

Lynx Air adds Saskatchewan with the addition of Regina to its expanding network

Retrieved on: 
Wednesday, January 17, 2024

REGINA, Saskatchewan, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Lynx Air (Lynx), announced today the addition of Regina to its network starting June 20, 2024, marking Lynx’s first expansion into the Saskatchewan market and making the total number of North American destinations served by Lynx to twenty-three.

Key Points: 
  • REGINA, Saskatchewan, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Lynx Air (Lynx), announced today the addition of Regina to its network starting June 20, 2024, marking Lynx’s first expansion into the Saskatchewan market and making the total number of North American destinations served by Lynx to twenty-three.
  • There will be six weekly flights on each route in and out of Regina to Vancouver and Toronto.
  • The sale will run until 11:59 PM CST on January 18, 2024, and is accessible with promo code: REGINA.
  • “We are excited to be adding Regina to the Lynx Air network in the lead up to summer.

Middlesex Water $52 Million Plant to Treat Ground Water for PFAS Compounds Now in Service

Retrieved on: 
Tuesday, July 25, 2023

The plant is treating groundwater in compliance with all state and federal drinking water standards.

Key Points: 
  • The plant is treating groundwater in compliance with all state and federal drinking water standards.
  • In 2021, the New Jersey Department of Environmental Protection (NJDEP) adopted a new regulation, or Maximum Contaminant Level (MCL), for one of the more prevalent per-and polyfluoroalkyl substances (PFAS) compounds, PFOA.
  • While the drinking water delivered by Middlesex met all existing regulatory standards at the time, when the new MCL became effective, the Park Avenue Plant initially exceeded the new PFOA standard.
  • These alternate sources of supply helped ensure water delivered, from that time forward, was in compliance with all drinking water standards.

Wisconsin Historical Society Offers First Look Inside New History Center

Retrieved on: 
Tuesday, June 13, 2023

MADISON, Wis., June 13, 2023 /PRNewswire-PRWeb/ -- The Wisconsin Historical Society is excited to share a first look inside the new state-of-the-art history center that is expected to be completed in late 2026. The history center will sit squarely at the intersection of Madison's vibrant State Street and Wisconsin's Capitol Square, serving as a hub of community engagement and civic activity. The five-story, 100,000-square-foot landmark will provide unprecedented access to the state's venerable collection of nearly 290 million items, while sharing regional stories within the context of American history.

Key Points: 
  • Designed to be a vibrant gathering place and regional learning hub, Wisconsin's new history center will be a leading cultural experience in the Midwest
    MADISON, Wis., June 13, 2023 /PRNewswire-PRWeb/ -- The Wisconsin Historical Society is excited to share a first look inside the new state-of-the-art history center that is expected to be completed in late 2026.
  • "This will be a welcoming, vibrant place for the community to gather, engage, reflect and share in our history."
  • The history center replaces the Wisconsin Historical Museum, which was located in the space of a former hardware store and unable to adequately provide access to the state's collections to school groups and residents.
  • "We are grateful for nearly two decades of growing public and private support, and we are thrilled to see Wisconsin's new history center visible on the horizon."

Ed O'Farrell Joins Institutional Real Estate, Inc. as Managing Director, Real Assets Adviser

Retrieved on: 
Monday, April 10, 2023

SAN RAMON, Calif. and SINGAPORE and LONDON, April 10, 2023 /PRNewswire/ -- Institutional Real Estate, Inc. (IREI) announced today that Ed O'Farrell has joined IREI as Managing Director of Real Assets Adviser magazine.

Key Points: 
  • SAN RAMON, Calif. and SINGAPORE and LONDON, April 10, 2023 /PRNewswire/ -- Institutional Real Estate, Inc. (IREI) announced today that Ed O'Farrell has joined IREI as Managing Director of Real Assets Adviser magazine.
  • Most recently, he worked as Regional Sales Manager at Pensions & Investments, where he sold publishing products to asset managers in the institutional investment vertical.
  • Prior to this, he worked for a publishing start-up, New Project Media, as Sales Director, covering renewable energy intelligence and data.
  • As Managing Director, Mr. O'Farrell will be responsible for client relations, business development and sales for Real Assets Adviser .

MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD Conference

Retrieved on: 
Wednesday, February 22, 2023

Dr. Kevin Kaiserman, Vice President, Medical Affairs, Endocrine Business Unit for MannKind, will report meal challenge results from the Afrezza with Basal Combination proof-of-concept study during an oral presentation delivered on Feb 25.

Key Points: 
  • Dr. Kevin Kaiserman, Vice President, Medical Affairs, Endocrine Business Unit for MannKind, will report meal challenge results from the Afrezza with Basal Combination proof-of-concept study during an oral presentation delivered on Feb 25.
  • Subjects utilizing TI also experienced a significantly lower mean PPG from 45 to 120 minutes post-meal.
  • The inhaled TI dosing used in this trial simplified the conversion from RAA that is contained in the current prescribing information.
  • Additional analysis from the ABC trial is expected to be presented at future conferences.

Recruitics Announces Three Executive Appointments To Drive Growth

Retrieved on: 
Thursday, February 16, 2023

NORWALK, Conn., Feb. 16, 2023 /PRNewswire-PRWeb/ -- Recruitics, an award-winning, data-powered recruitment marketing firm, bolstered its executive leadership team with the promotion of Ryan Christoi to President, Enterprise Division, Matt Grover to President, Digital Division, and the appointment of Sean Quigley as Vice President, Product. These are the latest in a series of organizational realignments aimed at accelerating growth, elevating operations, and enhancing product innovation.

Key Points: 
  • These are the latest in a series of organizational realignments aimed at accelerating growth, elevating operations, and enhancing product innovation.
  • His technical experience, rapid execution, and track record of scaling high-performance product teams will help lead Recruitics through our next growth phase."
  • Christoi joined Recruitics in 2019 as Executive Vice President following the company's acquisition of KRT Marketing.
  • Grover successfully managed account teams that delivered double-digit revenue growth for the past three consecutive years.

A Major US Wireless Service Provider Uses OnviSource Fifth Generation AI-Driven Hyper Analytics to Improve Customer Loyalty

Retrieved on: 
Tuesday, January 24, 2023

PLANO, Texas, Jan. 24, 2023 /PRNewswire-PRWeb/ -- OnviSource announced today the deployment of its highly advanced and next generation analytics, called Intellecta™ Hyper Analytics, to a major U.S. wireless service provider and other customers. Intellecta Hyper Analytics is the fifth generation of Company's multichannel and automated analytics solution offered as software licenses or Software-as-a-Service (SaaS).

Key Points: 
  • Intellecta Hyper Analytics is the fifth generation of Company's multichannel and automated analytics solution offered as software licenses or Software-as-a-Service (SaaS).
  • The wireless service provider has been using OnviSource analytics, customer survey, and automation solutions for over 10 years, and the new Intellecta Hyper Analytics will significantly enhance their success in customer experience management.
  • A series of iApps deployed by OnviSource includes analytics applications such as automated quality assurance (AQA), teleservice AQA, customer retention analytics and others.
  • OnviSource has maintained highly affordable prices for Intellecta Hyper Analytics to encourage and democratize AI, analytics and automation.

MannKind to Present Two Posters at 22nd Annual Diabetes Technology Meeting

Retrieved on: 
Thursday, November 10, 2022

No severe hypoglycemia was observed in the TI groups using the higher dose conversion method described below.

Key Points: 
  • No severe hypoglycemia was observed in the TI groups using the higher dose conversion method described below.
  • MannKind remains committed to improving options for mealtime control for patients living with diabetes.
  • MannKind also sponsored Poster# DESB2134D Simulating the Impact of Diabetes Therapy Engagement on Outcomes which will be presented by Lane Desborough, CEO of Nudge BG.
  • AFREZZA, TECHNOSPHERE and MANNKIND are registered trademarks of MannKind Corporation.